研究论文
The current and emerging immunotherapy paradigm in small-cell lung cancer
Kang Qin, Carl M. Gay, Lauren A. Byers, Jianjun Zhang
The University of Texas MD Anderson Cancer Center
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
1790
25
1726
关键指标
20
被引次数 · OpenAlex
9.14
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 1%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
162
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Lung Cancer Research Studies
Neuroendocrine Tumor Research Advances · Peptidase Inhibition and Analysis
参考文献 162
Subcutaneous interleukin-2 as initial therapy for patients with extensive small cell lung cancer:
被引 7Gerald H. Clamon, James Herndon, Wallace Akerley · Lung Cancer · 1998
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
被引 545Wei Wang · Frontiers in Immunology · 2015
Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO)
被引 145Claire H. Kim, Yuan-Chin Amy Lee, Rayjean J. Hung · International Journal of Cancer · 2014
此处列出前 3 条
引用本文 20
Lung cancer immunotherapy in 2025: where we stand and what comes next?
被引 8Jie Han, Zhibo Yang, Zhao Hai · Frontiers in Immunology · 2026
Targeting the powerhouse: A critical review of mitochondrial inhibitors as a therapeutic strategy in lung cancer
被引 3Woo Hyun Park · European Journal of Pharmacology · 2025
Real-World Effectiveness and Safety of Immune Checkpoint Inhibitors Combined with Chemotherapy in Taiwanese Patients with Extensive-Stage Small Cell Lung Cancer
被引 2Cheng‐Yu Chang, Yu‐Feng Wei, Shih-Chieh Chang · Current Oncology · 2025
按被引量排序，此处列出前 3 条